Search Results 431-440 of 18059 for progesterone

1. A Study Comparing Combinations of Chemotherapy for Treating Women who have Undergone Surgery for Node-Positive Breast Cancer - Mayo Clinic

   Must have an estrogen receptor analysis performed on the primary tumor prior to randomization. If negative, then progesterone receptor analysis must be ...

2. Follitropin alfa (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Follitropin alfa is a hormone identical to follicle-stimulating hormone (FSH) produced by the pituitary gland. FSH helps to develop eggs in the ovaries.

3. Publications - Jewel M. Kling, M.D., M.P.H. - Mayo Clinic

   A Comprehensive Review of Estradiol, Progesterone, Luteinizing Hormone, and Follicle-Stimulating Hormone in the Context of Laboratory Medicine to Support ...

4. vaginal atrophy Archives - Mayo Clinic News Network

   ... progesterone receptor positive) cancer. These options include: Vaginal moisturizers. Over-the-counter products like K-Y Liquibeads, Replens and Sliquid ...

5. PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer - Mayo Clinic

   ... progesterone, rifampin, phenobarbital, St. John's wort). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for ...

6. Viral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer - Mayo Clinic

   ... progesterone receptor (PR)/human epidermal growth factor receptor 2 (HER2) status and radiographic evidence of distant metastatic disease; Measurable disease ...

7. Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer - Mayo Clinic

   Current use of systemic or topical exogenous estrogen or progesterone (menopausal hormone replacement therapy [HRT]). Prior ovarian function suppression ...

8. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

   (Note that the guidelines use PR as the abbreviation for progesterone receptor.) Cohort C: Must have histologically or cytologically documented, advanced or ...

9. Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer - Mayo Clinic

   - Estrogen receptor (ER) and/or progesterone receptor (PR/PgR) positive breast cancer (defined as > 1% of either receptor by IHC). - Any of the following ...

10. Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab - Mayo Clinic

    Use of oral, (estrogen and progesterone), injected or implanted hormonal methods of contraception or other forms of hormonal contraception that have ...